☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 4

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 4 (PDF).

This fourth issue contains the following drug safety advice articles:

  • Fibrates: new prescribing advice
  • Lumiracoxib: hepatotoxicity
  • Ceftriaxone: incompatibility with calcium-containing solutions
  • Codeine: very rare risk of side-effects in breastfed babies
  • St John's wort: interactions with all antiepileptics

In addition, this issue contains hot topics focussing on some illegal herbal remedies and new restrictions of nasal decongestants. There is also a reminder to prescribers about the co-proxamol withdrawal.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 4' by emailShare 'Drug Safety Update, Issue 4' on FacebookShare 'Drug Safety Update, Issue 4' on TwitterShare 'Drug Safety Update, Issue 4' on LinkedInShare 'Drug Safety Update, Issue 4' on reddit


No Comments to “Drug Safety Update, Issue 4”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.